The Hereditary Thrombotic Thrombocytopenic Purpura Registry is the biggest worldwide Registry for patients with hereditary/congenital thrombotic thrombocytopenic purpura (hTTP), also known as Upshaw-Schulman syndrome.

 

Our main goal is to collect data about hTTP from as many patients and their relatives as possible. This helps us in better understanding the manifestations and the unmet needs of these patients associated with such rare disease.

 

If you have any questions about hereditary TTP, the Registry or our research activities, or if you care for a patient with a potential diagnosis of hTTP, or want to discuss an hTTP case, please contact us at support@ttpregistry.net.

News

Today, the U.S. Food and Drug Administration approved Adzynma, the first recombinant (genetically engineered) protein product indicated for prophylactic (preventive) or on demand enzyme replacement...

Takeda Announces Favorable Phase 3 Safety and Efficacy Results of TAK-755 as Compared to Standard of Care in Congenital Thrombotic Thrombocytopenic Purpura (cTTP)

Podcast about strokes in hTTP from Azra's article in Blood 

Azra Borogovac published her work about neuropsychiatric symptoms and strokes in hTTP Patients in Blood. 
To read the full article, click here.

Monica presented the winning poster entitled "Substantial differences in the immune response to ADAMTS13 in immunemediated and in plasma-treated hereditary Thrombotic Thrombocytopenic Purpura (TTP)"...

The highest and prestigious award of the Society of Thrombosis and Hemostatis (GTH), the Alexander Schmidt Preis 2022 was awarded to Prof. Johanna Kremer due to her devotion and work in the filed of...

Second publication from the Hereditary TTP Registry released online  
Please click here to see the scientific publication

13 January 2021 THANK YOU  

The TTP team-Bern would like to thank you and cheers with you for attending the  first virtual meeting "TTP patient evening".

Stay healthy and see you next year 

Subscribe to our annual Newsletter

Our annual Newsletter will be sent to you in December each year. Sign up to keep updated.